New developments in the management of hepatitis C virus infection: focus on boceprevir
Marina Berenguer,1–3 F Xavier López-Labrador4–61Hepatology-Liver Transplantation Unit, Digestive Medicine Service, Hospital Universitari La Fe, Valencia, Spain; 2Department of Medicine, University of Valencia, Valencia, Spain; 3CIBERehd, Instituto de Salud...
Enregistré dans:
Auteurs principaux: | Berenguer M, López-Labrador FX |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/76dc9770a0764ccb96417a8c9b27b59f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Treatment of experienced and naïve patients with hepatitis C: focus on telaprevir
par: D'Ambrosio R, et autres
Publié: (2012) -
New treatment options in the management of IBD – focus on colony stimulating factors
par: Josué Barahona-Garrido, et autres
Publié: (2008) -
Impact of Hepatitis C Virus Co-Infection on Tuberculous Patients
par: Eman Nageeb, et autres
Publié: (2021) -
A new evolutionary model for hepatitis C virus chronic infection.
par: Rebecca R Gray, et autres
Publié: (2012) -
Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa
par: Liu CH, et autres
Publié: (2014)